Questions: Gastric Parietal Cell Secretion and Acid Production

Question 1

A patient with autoimmune gastritis has antibodies that progressively destroy gastric parietal cells. Which combination of findings would you expect?

• A. Achlorhydria alone — parietal cells only produce acid, so only acid production is lost
• B. Both achlorhydria and pernicious anemia — parietal cells produce both HCl and intrinsic factor, which is required for vitamin B12 absorption
• C. Pernicious anemia but not achlorhydria — G cells compensate for acid production
• D. Achlorhydria only in the fasting state — parietal cells are inactive between meals

Answer: (B)

Parietal cells have a dual function: they secrete hydrochloric acid via the proton pump and produce intrinsic factor, a glycoprotein required for B12 absorption in the terminal ileum. Destroying the parietal cells eliminates both functions simultaneously. Achlorhydria leads to impaired protein digestion and altered gastric flora; intrinsic factor loss causes B12 deficiency, leading to megaloblastic anemia and neurological damage (pernicious anemia). Option (a) reflects the misconception that parietal cells only make acid.

Question 2

A patient taking omeprazole (a proton pump inhibitor) for acid reflux asks how it works. Which mechanism is correct?

• A. It blocks histamine H2 receptors on parietal cells, preventing the most potent stimulator of acid secretion
• B. It neutralizes stomach acid directly by acting as a buffer in the gastric lumen
• C. It irreversibly inhibits H+/K+-ATPase, blocking the final common step in proton secretion regardless of which upstream pathway stimulated it
• D. It blocks gastrin receptors on parietal cells, preventing the postprandial rise in acid secretion

Answer: (C)

Proton pump inhibitors (PPIs) target H+/K+-ATPase — the proton pump that performs the final step of H+ secretion. Because PPIs block the shared effector mechanism, they are more effective than pathway-specific agents like H2 antagonists (ranitidine, which blocks histamine receptors) or gastrin receptor blockers. PPIs do not neutralize acid in the lumen and do not block upstream receptors. Irreversibly inhibiting the pump means new pump synthesis is required before acid secretion fully resumes.

Question 3

The alkaline tide — a transient rise in blood pH in venous blood draining the stomach during active acid secretion — occurs because bicarbonate produced alongside H+ inside parietal cells is exported into the bloodstream.

• T. True
• F. False

Answer: True

Inside parietal cells, carbonic anhydrase converts CO₂ and H₂O into H₂CO₃, which dissociates into H⁺ and HCO₃⁻. The H⁺ is pumped into the gastric lumen by H+/K+-ATPase. The HCO₃⁻ exits across the basolateral membrane via a Cl⁻/HCO₃⁻ exchanger into the blood. During active acid secretion, this export of bicarbonate raises blood pH in the stomach's venous drainage — the alkaline tide. This is also why blood HCO₃⁻ rises in conditions of chronic acid loss, such as prolonged vomiting.

Question 4

Long-term use of proton pump inhibitors typically causes pernicious anemia because PPIs suppress intrinsic factor production along with acid secretion.

• T. True
• F. False

Answer: False

PPIs inhibit the proton pump in parietal cells but do not destroy the cells. Parietal cells remain intact and continue producing intrinsic factor. B12 absorption is therefore largely preserved with PPI use. Pernicious anemia due to intrinsic factor deficiency requires actual loss of parietal cells — as in autoimmune gastritis where antibodies destroy parietal cells or block intrinsic factor. PPIs can reduce B12 absorption slightly through other mechanisms (acid helps release B12 from food protein), but this is modest and distinct from true intrinsic factor deficiency.

Question 5

Why do three separate signaling pathways — acetylcholine, gastrin, and histamine — converge on parietal cells, and what clinical advantage does this multi-pathway architecture create?

Model answer: Each pathway corresponds to a distinct phase of digestion: acetylcholine from the vagus nerve activates during the cephalic phase (sight, smell, and anticipation of food), allowing acid secretion to begin before food arrives. Gastrin from antral G cells activates during the gastric phase when food physically distends the stomach and protein arrives. Histamine from ECL cells amplifies both signals and sustains acid output during digestion. Clinically, because each pathway is a separate point of intervention, blocking any one significantly reduces total acid output — providing multiple pharmacological targets. PPIs, which block the final common mechanism (the proton pump), are most effective because they suppress acid regardless of which upstream pathway drives it.

The three pathways also potentiate each other — histamine sensitizes parietal cells to both acetylcholine and gastrin, explaining why H2 receptor antagonists reduce acid output far more than the histamine pathway alone would suggest. This convergent architecture achieves both temporal fine-tuning (phase-specific control) and robust, sustained acid production during meals.